| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $944.8M | +9.1% |
| Cost of Revenue | $231.0M | +0.3% |
| Gross Profit | $713.8M | +12.2% |
| R&D Expense | $201.5M | +16.4% |
| SG&A Expense | $218.2M | +13.7% |
| Operating Income | $80.1M | +434.8% |
| Interest Expense | $64.6M | +1.6% |
| Pre-tax Income | $44.3M | +152.4% |
| Income Tax | $13.1M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $399.0M | +104.0% |
| Accounts Receivable | $106.6M | +4.1% |
| Current Assets | $564.6M | +61.3% |
| Total Assets | $3.18B | +4.3% |
| Current Liabilities | $154.8M | +1.3% |
| Long-term Debt | $776.0M | -1.0% |
| Total Liabilities | $1.16B | -7.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $283.9M | +13.5% |
| Capital Expenditures | $53.0M | -3.7% |
| Investing Cash Flow | -$53.0M | +3.7% |
| Financing Cash Flow | -$27.3M | +91.6% |
| Free Cash Flow | $230.9M | +18.4% |
| +136.7% |
| Net Income | $31.2M | +134.7% |
| EPS (Basic) | $0.04 | +126.7% |
| EPS (Diluted) | $0.04 | +126.7% |
| Stockholders' Equity |
| $2.00B |
| +12.1% |